Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol vs Sufentanil for Laparoscopic Cholecystectomy
NCT07019818Phase 4Recruiting
- Sponsor
- CHU de Limoges
- Start
- Oct 2025
- Primary completion
- Jan 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esmolol in cholecystectomy (2 arms), sponsored by CHU de Limoges. Primary endpoint: Quality of Recovery at 2 days. Started Oct 2025; status: recruiting.
02
Drugs
esmolol
03
Conditions
cholecystectomy
Beyond the preview
Go deeper on NCT07019818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07019818.